Atypical
BRAF
MAPK
NRAS
mucosal melanoma
mutations
targeted therapies
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
08 Aug 2019
08 Aug 2019
Historique:
received:
05
07
2019
revised:
06
08
2019
accepted:
07
08
2019
entrez:
11
8
2019
pubmed:
11
8
2019
medline:
11
8
2019
Statut:
epublish
Résumé
Primary mucosal melanomas represent a minority of melanomas, but have a significantly worse prognosis than cutaneous melanomas. A better characterization of the molecular pathogenesis of this melanoma subtype could help us understand the risk factors associated with the development of mucosal melanomas and highlight therapeutic targets. Because the Mitogen-Activated Protein Kinase (MAPK) pathway plays such a significant role in melanoma development, we explore v-raf murine sarcoma viral oncogene homolog B (
Identifiants
pubmed: 31398831
pii: cancers11081133
doi: 10.3390/cancers11081133
pmc: PMC6721527
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Fondation ARC pour la Recherche sur le Cancer
ID : PJA2017206199
Organisme : Ligue Contre le Cancer
ID : RS17/75-20
Organisme : Institut National de la Santé et de la Recherche Médicale
ID : U976
Organisme : Université Paris Diderot
ID : UMRS_976
Organisme : Gefluc Paris IdF
ID : Nicolas DUMAZ
Références
J Pathol. 1999 Mar;187(4):433-8
pubmed: 10398103
Oncogene. 1992 Sep;7(9):1729-36
pubmed: 1501884
Cell. 2004 Mar 19;116(6):855-67
pubmed: 15035987
Biochem Biophys Res Commun. 1992 Sep 16;187(2):809-13
pubmed: 1530636
Nat Rev Mol Cell Biol. 2004 Nov;5(11):875-85
pubmed: 15520807
Cancer Res. 1992 Jul 15;52(14):3946-51
pubmed: 1617670
Mol Cell. 2005 Dec 22;20(6):963-9
pubmed: 16364920
Nature. 2007 Feb 22;445(7130):851-7
pubmed: 17314971
Cell. 2007 Jun 1;129(5):865-77
pubmed: 17540168
Structure. 2007 Dec;15(12):1618-29
pubmed: 18073111
Nat Rev Mol Cell Biol. 2008 Jul;9(7):517-31
pubmed: 18568040
Oncogene. 2009 Jan 8;28(1):85-94
pubmed: 18794803
Clin Cancer Res. 2008 Dec 1;14(23):7726-32
pubmed: 19047099
Mol Oncol. 2008 Apr;1(4):395-405
pubmed: 19383313
Br J Ind Med. 1991 Jan;48(1):9-11
pubmed: 1993163
Cell. 2010 Jan 22;140(2):209-21
pubmed: 20141835
Cancer Res. 2010 Nov 1;70(21):8475-86
pubmed: 20978199
Oncogene. 2011 Aug 11;30(32):3477-88
pubmed: 21577205
J Clin Oncol. 2011 Jul 20;29(21):2904-9
pubmed: 21690468
Genes Cancer. 2011 Mar;2(3):232-60
pubmed: 21779496
Eur J Cancer. 2012 Jan;48(1):94-100
pubmed: 21788131
Nat Rev Cancer. 2011 Oct 13;11(11):761-74
pubmed: 21993244
Invest New Drugs. 2012 Oct;30(5):2008-14
pubmed: 22068222
J Natl Cancer Inst. 2012 Feb 8;104(3):228-39
pubmed: 22247021
Clin Cancer Res. 2012 Mar 1;18(5):1457-63
pubmed: 22261812
Cancer Res. 2012 May 15;72(10):2457-67
pubmed: 22589270
Nat Genet. 2012 Sep;44(9):1006-14
pubmed: 22842228
Mol Cell. 2013 Feb 21;49(4):751-8
pubmed: 23352452
Lancet Oncol. 2013 Mar;14(3):249-56
pubmed: 23414587
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4574-9
pubmed: 23487764
J Pathol. 2013 Jul;230(3):261-9
pubmed: 23620124
J Clin Oncol. 2013 Sep 10;31(26):3182-90
pubmed: 23775962
Int J Cancer. 2014 Jun 15;134(12):2961-71
pubmed: 24272143
J Am Acad Dermatol. 2014 Aug;71(2):229-36
pubmed: 24842760
Cancer Discov. 2014 Dec;4(12):1418-29
pubmed: 25252692
Melanoma Res. 2015 Feb;25(1):88-90
pubmed: 25304235
Nat Rev Drug Discov. 2014 Nov;13(11):828-51
pubmed: 25323927
J Clin Invest. 2015 Jan;125(1):222-33
pubmed: 25437878
Nat Rev Mol Cell Biol. 2015 May;16(5):281-98
pubmed: 25907612
Mol Cancer Res. 2015 Sep;13(9):1325-35
pubmed: 26037647
J Cell Sci. 2016 Apr 1;129(7):1287-92
pubmed: 26985062
APMIS. 2016 Jun;124(6):475-86
pubmed: 27004972
Nat Rev Dis Primers. 2015 Apr 23;1:15003
pubmed: 27188223
J Invest Dermatol. 2016 Sep;136(9):1858-1865
pubmed: 27220476
Oncologist. 2016 Jul;21(7):848-54
pubmed: 27286787
Eur J Cancer. 2016 Sep;65:156-63
pubmed: 27498141
Cancer Cell. 2016 Sep 12;30(3):485-498
pubmed: 27523909
Cancer. 2016 Nov 15;122(21):3354-3362
pubmed: 27533633
J Am Acad Dermatol. 2017 Feb;76(2):250-257
pubmed: 27742175
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13456-13461
pubmed: 27834212
J Clin Oncol. 2017 Jan 10;35(2):226-235
pubmed: 28056206
Melanoma Res. 2017 Jun;27(3):189-199
pubmed: 28296713
Oncotarget. 2017 Jun 20;8(25):40683-40692
pubmed: 28380455
Oncotarget. 2017 May 9;8(19):32258-32269
pubmed: 28416755
Nature. 2017 May 11;545(7653):175-180
pubmed: 28467829
Nat Commun. 2017 May 12;8:15262
pubmed: 28497782
J Invest Dermatol. 2018 Jan;138(1):58-67
pubmed: 28843487
Onco Targets Ther. 2017 Aug 08;10:3941-3947
pubmed: 28860801
Nat Rev Cancer. 2017 Nov;17(11):676-691
pubmed: 28984291
J Pathol. 2018 Mar;244(3):358-366
pubmed: 29230811
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Science. 2018 Nov 30;362(6418):1055-1060
pubmed: 30385465
Nat Med. 2019 Feb;25(2):221-224
pubmed: 30510256
Oncogene Res. 1988;3(1):9-20
pubmed: 3060800
Oncotarget. 2019 Jan 29;10(9):930-941
pubmed: 30847022
Nature. 1984 Nov 1-7;312(5989):71-5
pubmed: 6092966
Scand J Dent Res. 1982 Dec;90(6):434-42
pubmed: 6961509